Page last updated: 2024-09-03

marimastat and Sepsis

marimastat has been researched along with Sepsis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Horiuchi, M; Mita, S; Okahara, A; Oki, K; Sasano, M; Suhara, H; Tsuji, F; Yamanouchi, T	1

Other Studies

1 other study(ies) available for marimastat and Sepsis

Article	Year
Differential effects between marimastat, a TNF-alpha converting enzyme inhibitor, and anti-TNF-alpha antibody on murine models for sepsis and arthritis. Cytokine, 2002, Mar-21, Volume: 17, Issue:6 Topics: ADAM Proteins; ADAM17 Protein; Animals; Antibodies; Arthritis, Experimental; Disease Models, Animal; Enzyme Inhibitors; Humans; Hydroxamic Acids; Lipopolysaccharides; Metalloendopeptidases; Mice; Mice, Inbred BALB C; Mice, Transgenic; Sepsis; Tumor Necrosis Factor-alpha	2002

Article

Year

Differential effects between marimastat, a TNF-alpha converting enzyme inhibitor, and anti-TNF-alpha antibody on murine models for sepsis and arthritis.

Cytokine, 2002, Mar-21, Volume: 17, Issue:6

Topics: ADAM Proteins; ADAM17 Protein; Animals; Antibodies; Arthritis, Experimental; Disease Models, Animal; Enzyme Inhibitors; Humans; Hydroxamic Acids; Lipopolysaccharides; Metalloendopeptidases; Mice; Mice, Inbred BALB C; Mice, Transgenic; Sepsis; Tumor Necrosis Factor-alpha

2002